CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Robotic Surgical Systems for Use in Gynecologic Oncology or Urologic Surgery: Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Last updated: April 13, 2020
Project Number: RB1430-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of robotic surgical systems for use in gynecologic oncology or urologic surgery?
  2. What is the cost-effectiveness of robotic surgical systems for use in gynecologic oncology or urologic surgery?
  3. What are the evidence-based guidelines regarding the use of robotic surgical systems in gynecologic oncology or urologic surgery?

Key Message

Three health technology assessment reports, nine systematic reviews (four with meta-analyses), and eight non-randomized studies were identified regarding the clinical effectiveness of robotic surgical systems for use in gynecologic oncology or urologic surgery. Two economic evaluations were identified regarding the cost-effectiveness of robotic surgical systems for use in gynecologic oncology or urologic surgery. Seven evidence-based guidelines were identified regarding the use of robotic surgical systems in gynecologic oncology or urologic surgery.